Current Treatment of Alopecia Areata

J Investig Dermatol Symp Proc. 2020 Nov;20(1):S28-S30. doi: 10.1016/j.jisp.2020.04.004.

Abstract

The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Cutaneous
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Alopecia Areata / drug therapy*
  • Clinical Decision-Making
  • Clinical Laboratory Techniques
  • Humans
  • Injections, Intralesional
  • Janus Kinase Inhibitors / therapeutic use*
  • Medical History Taking
  • Minoxidil / therapeutic use
  • Physical Examination
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Janus Kinase Inhibitors
  • Vasodilator Agents
  • Minoxidil